Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Liver Diseases

  Free Subscription


Articles published in Br J Surg

Retrieve available abstracts of 95 articles:
HTML format



Single Articles


    October 2024
  1. GIANNONE F, Del Zompo F, Saviano A, Pencreach E, et al
    Impact of genetic alterations on long-term outcomes in resectable intrahepatic cholangiocarcinoma: meta-analysis.
    Br J Surg. 2024;111:znae257.
    PubMed     Abstract available


  2. PERRI G, Sparrelid E, Siriwardena AK, Marchegiani G, et al
    Estimation of intraoperative blood loss in hepatopancreatobiliary surgery: a Delphi consensus process of the European-African Hepato-Pancreato-Biliary Association (E-AHPBA).
    Br J Surg. 2024;111:znae256.
    PubMed    


    August 2024
  3. PAOLUCCI I, Albuquerque Marques Silva J, Lin YM, Laimer G, et al
    Identification of A0 minimum ablative margins for colorectal liver metastases: multicentre, retrospective study using deformable CT registration and artificial intelligence-based autosegmentation.
    Br J Surg. 2024;111:znae165.
    PubMed     Abstract available


  4. SOREIDE K, Kok NFM
    Curative-intent ablation margins (A0) for colorectal liver metastasis: more burning questions.
    Br J Surg. 2024;111:znae184.
    PubMed    


  5. KITAHAMA T, Ashida R, Ohgi K, Yamada M, et al
    Laparoscopic right anterior inferior segmentectomy for hepatocellular carcinoma in a patient with congenital absence of the portal vein: intrahepatic artery-guided simulation.
    Br J Surg. 2024;111:znae210.
    PubMed    


  6. BOZKURT E, Sijberden JP, Langella S, Cipriani F, et al
    Laparoscopic versus open right hepatectomy for colorectal liver metastases after portal vein embolization: international multicentre study.
    Br J Surg. 2024;111:znae181.
    PubMed     Abstract available


    July 2024
  7. BAHRI S, Brown L, Perin G, Balasubramanian SP, et al
    Comment on: Laparoscopic liver resection versus radiofrequency ablation for small hepatocellular carcinoma: randomized clinical trial.
    Br J Surg. 2024;111:znae171.
    PubMed    


  8. MARGONIS GA, Wang JJ, Boerner T, Moretto R, et al
    Hepatectomy versus systemic therapy for liver-limited BRAF V600E-mutated colorectal liver metastases: multicentre retrospective study.
    Br J Surg. 2024;111:znae176.
    PubMed     Abstract available


    May 2024
  9. OLTHOF K, Smit J, Fusaglia M, Kok N, et al
    A surgical navigation system to aid the ablation of vanished colorectal liver metastases.
    Br J Surg. 2024;111:znae110.
    PubMed    


  10. JONES RP
    Lesional liver biopsies: better treatments, better studies, better science.
    Br J Surg. 2024;111:znae063.
    PubMed    


  11. DE GRAAFF MR, Hendriks TE, Wouters M, Nielen M, et al
    Assessing quality of hepato-pancreato-biliary surgery: nationwide benchmarking.
    Br J Surg. 2024;111:znae119.
    PubMed     Abstract available


    April 2024
  12. KRUL MF, Kok NFM, Osmani H, Buisman FE, et al
    Hepatic arterial infusion pump chemotherapy combined with systemic chemotherapy for borderline resectable and unresectable colorectal liver metastases: phase II feasibility study.
    Br J Surg. 2024;111:znae089.
    PubMed     Abstract available


  13. AKABANE M, Bekki Y, Imaoka Y, Inaba Y, et al
    Impact of donor characteristics on hepatocellular carcinoma recurrence after liver transplantation.
    Br J Surg. 2024;111:znae080.
    PubMed    


  14. JOLIAT GR, de Man R, Rijckborst V, Cimino M, et al
    Long-term outcomes of ruptured hepatocellular carcinoma: international multicentre study.
    Br J Surg. 2024;111:znae093.
    PubMed    


  15. KORENBLIK R, Heil J, Smits J, James S, et al
    Liver regeneration after portal and hepatic vein embolization improves overall survival compared with portal vein embolization alone: mid-term survival analysis of the multicentre DRAGON 0 cohort.
    Br J Surg. 2024;111:znae087.
    PubMed     Abstract available


  16. SONG J, Cao L, Ma K, Li J, et al
    Laparoscopic liver resection versus radiofrequency ablation for small hepatocellular carcinoma: randomized clinical trial.
    Br J Surg. 2024;111:znae099.
    PubMed     Abstract available


    March 2024
  17. PENG W, Wu Y, Zhang X, Li C, et al
    Liver transplantation for advanced hepatocellular carcinoma after downstaging with consequential lenvatinib, transcatheter arterial chemoembolization and camrelizumab.
    Br J Surg. 2024;111:znae048.
    PubMed    


  18. FAN ZQ, Serenari M, Lv X, Schwartz M, et al
    Prognostic significance of nodular number in patients undergoing hepatectomy of intermediate-stage hepatocellular carcinoma.
    Br J Surg. 2024;111:znae047.
    PubMed    


  19. MAJLESARA A, Golriz M, Ramouz A, Khajeh E, et al
    Portal vein arterialization as a salvage method in advanced hepatopancreatobiliary surgery.
    Br J Surg. 2024;111:znae053.
    PubMed    


  20. MARTIN-CULLELL B, Virgili AC, Riera P, Fumagalli C, et al
    Histopathological, Clinical, And Molecular (HICAM) score for patients with colorectal liver metastases.
    Br J Surg. 2024;111:znae016.
    PubMed     Abstract available


    January 2024
  21. BAUMGARTNER R, Engstrand J, Rajala P, Grip J, et al
    Comparing the accuracy of prediction models to detect clinically relevant post-hepatectomy liver failure early after major hepatectomy.
    Br J Surg. 2024;111:znad433.
    PubMed     Abstract available


  22. TZEDAKIS S, Yzhaky Shapira O, Schwarzinger M, Katsahian S, et al
    COVID-19 and excess mortality of patients with liver cancer in France, January 2020-September 2022.
    Br J Surg. 2024;111:znad359.
    PubMed    


  23. ENDO Y, Pawlik TM
    Author response to: Comment on: Liver transplantation for elderly patients with early-stage hepatocellular carcinoma.
    Br J Surg. 2024;111:znad423.
    PubMed    


  24. MALIK AK, Figueiredo R, White SA
    Comment on: Liver transplantation for elderly patients with early-stage hepatocellular carcinoma.
    Br J Surg. 2024;111:znad426.
    PubMed    


    November 2023
  25. ARNTZ P, Olthof PB
    Assessment of liver function before major hepatectomy.
    Br J Surg. 2023;110:1588-1589.
    PubMed    


    October 2023

  26. Corrigendum to: Variation in treatment of intrahepatic cholangiocarcinoma: a nationwide multicentre study.
    Br J Surg. 2023 Oct 31:znad365. doi: 10.1093.
    PubMed    


    September 2023
  27. PRIMAVESI F, Maglione M, Cipriani F, Denecke T, et al
    E-AHPBA-ESSO-ESSR Innsbruck consensus guidelines for preoperative liver function assessment before hepatectomy.
    Br J Surg. 2023;110:1331-1347.
    PubMed     Abstract available


  28. KATAOKA K, Takahashi K, Takeuchi J, Ito K, et al
    Author response to: Comment on: Correlation between recurrence-free survival and overall survival after upfront surgery for resected colorectal liver metastases.
    Br J Surg. 2023;110:1407.
    PubMed    


  29. VOIGT KR, Wullaert L, de Graaff MR, Verhoef C, et al
    Association between textbook outcome and long-term survival after surgery for colorectal liver metastases.
    Br J Surg. 2023;110:1284-1287.
    PubMed    


    August 2023
  30. MCCLEMENTS J, Valle JW, Blackburn L, Brooks A, et al
    Variation in treatment of intrahepatic cholangiocarcinoma: a nationwide multicentre study.
    Br J Surg. 2023 Aug 23:znad259. doi: 10.1093.
    PubMed    


  31. VAN REES JM, Krul MF, Kok NFM, Grunhagen DJ, et al
    Treatment of locally advanced rectal cancer and synchronous liver metastases: multicentre comparison of two treatment strategies.
    Br J Surg. 2023;110:1049-1052.
    PubMed    


  32. ENDO Y, Sasaki K, Moazzam Z, Lima HA, et al
    Liver transplantation for elderly patients with early-stage hepatocellular carcinoma.
    Br J Surg. 2023 Aug 7:znad243. doi: 10.1093.
    PubMed     Abstract available


    July 2023
  33. UUTELA A, Nordin A, Osterlund E, Halonen P, et al
    Resectability and resection rates of colorectal liver metastases according to RAS and BRAF mutational status: prospective study.
    Br J Surg. 2023;110:931-935.
    PubMed    


  34. SIRIWARDENA AK, Serrablo A, Fretland AA, Wigmore SJ, et al
    Multisocietal European consensus on the terminology, diagnosis, and management of patients with synchronous colorectal cancer and liver metastases: an E-AHPBA consensus in partnership with ESSO, ESCP, ESGAR, and CIRSE.
    Br J Surg. 2023 Jul 14:znad124. doi: 10.1093.
    PubMed     Abstract available


    June 2023
  35. KATAOKA K, Takahashi K, Takeuchi J, Ito K, et al
    Correlation between recurrence-free survival and overall survival after upfront surgery for resected colorectal liver metastases.
    Br J Surg. 2023;110:864-869.
    PubMed     Abstract available


  36. MAJLESARA A, Aminizadeh E, Ramouz A, Khajeh E, et al
    Evidence mapping of randomized clinical trials in hepatobiliary surgery.
    Br J Surg. 2023 Jun 1:znad125. doi: 10.1093.
    PubMed    


    February 2023
  37. WENSINK GE, Bolhuis K, Elferink MAG, Fijneman RJA, et al
    Predicting early extrahepatic recurrence after local treatment of colorectal liver metastases.
    Br J Surg. 2023;110:362-371.
    PubMed     Abstract available


    January 2023
  38. PRIMAVESI F, Stattner S, Maglione M
    European guidelines for assessment of liver function before hepatectomy.
    Br J Surg. 2023;110:166-168.
    PubMed    


    December 2022
  39. ZHOU Y
    Comment on: Pathophysiological mechanisms of ALPPS: experimental model.
    Br J Surg. 2022;110:117.
    PubMed    


  40. SIJBERDEN JP, Cipriani F, Lanari J, Russolillo N, et al
    Minimally invasive ver-sus open liver resection for hepatocellular carcinoma in the elderly: international multicentre propensity score-matched study.
    Br J Surg. 2022 Dec 13:znac423. doi: 10.1093.
    PubMed    


    November 2022
  41. CHERRIE A
    The end of an era.
    Br J Surg. 2022;109:1181.
    PubMed    


  42. WANG XH, Zhou QF, Wang CM, Xiang CL, et al
    Adjuvant transarterial chemoembolization for intermediate-stage hepatocellular carcinoma with microvascular invasion.
    Br J Surg. 2022 Nov 17. pii: 6832194. doi: 10.1093.
    PubMed    


    October 2022
  43. LOPEZ-LOPEZ V, Sanchez-Esquer I, Crespo MJ, Navarro MA, et al
    Development and validation of advanced three-dimensional navigation device integrated in da Vinci Xi(R) surgical robot for hepatobiliary surgery: pilot study.
    Br J Surg. 2022 Oct 26. pii: 6775136. doi: 10.1093.
    PubMed    


  44. D'SILVA M, Han HS, Liu R, Kingham TP, et al
    Limited liver resections in the posterosuperior segments: international multicentre propensity score-matched and coarsened exact-matched analysis comparing the laparoscopic and robotic approaches.
    Br J Surg. 2022;109:1140-1149.
    PubMed     Abstract available


  45. BUETTNER S, Olthof PB, Wang J, Kreis ME, et al
    Author response to: Comment on: KRAS alterations in colorectal liver metastases: shifting to exon, codon, and point mutations.
    Br J Surg. 2022;109:e122.
    PubMed    


  46. LIU QL, Chen HN
    Comment on: KRAS alterations in colorectal liver metastases: shifting to exon, codon, and point mutations.
    Br J Surg. 2022;109:e121.
    PubMed    


    September 2022
  47. PENG W, Zhang X, Li C, Zhu X, et al
    Programmed cell death protein 1 and tyrosine kinase inhibition plus transcatheter arterial chemoembolization of advanced hepatocellular carcinoma.
    Br J Surg. 2022 Sep 27. pii: 6718210. doi: 10.1093.
    PubMed    


  48. WONG D, Ng ZQ, Weber D
    Author response to: Comment on: Unfamiliar liver lesions.
    Br J Surg. 2022;109:e115.
    PubMed    


  49. DIAO X, Wei L, Zhou H
    Comment on: Unfamiliar liver lesions.
    Br J Surg. 2022;109:e114.
    PubMed    


    August 2022
  50. HOBEIKA C, Cauchy F
    Author response to: Comment on: Performance of non-invasive biomarkers compared with invasive methods for risk prediction of posthepatectomy liver failure in hepatocellular carcinoma.
    Br J Surg. 2022 Aug 18. pii: 6670912. doi: 10.1093.
    PubMed    


  51. HUO TI, Ho SY, Liao JI
    Comment on: Performance of non-invasive biomarkers compared with invasive methods for risk prediction of posthepatectomy liver failure in hepatocellular carcinoma.
    Br J Surg. 2022 Aug 18. pii: 6670908. doi: 10.1093.
    PubMed    


  52. OLTHOF PB, Buettner S, Andreatos N, Wang J, et al
    KRAS alterations in colorectal liver metastases: shifting to exon, codon, and point mutations.
    Br J Surg. 2022;109:804-807.
    PubMed    


    July 2022
  53. SIJBERDEN JP, Abu Hilal M
    Comment on: Synchronous resection of primary colorectal cancer with liver metastases: two birds with one stone?
    Br J Surg. 2022 Jul 16. pii: 6645296. doi: 10.1093.
    PubMed    


  54. PERY R, Smoot RL, Thiels CA, Cleary SP, et al
    Hepatobiliary and pancreatic resection for cholangiocarcinoma in patients with primary sclerosing cholangitis.
    Br J Surg. 2022 Jul 15. pii: 6644759. doi: 10.1093.
    PubMed    


    June 2022
  55. SHEN Q, Li T, Zhou J
    Comment on: Early postoperative arterial lactate concentrations to stratify risk of post-hepatectomy liver failure.
    Br J Surg. 2022;109:e85.
    PubMed    


    May 2022
  56. YOU J, Wu S, Fu Y, Meng L, et al
    Wrapping of the hepatic artery using the round ligament during laparoscopic pancreatoduodenectomy to prevent postpancreatectomy haemorrhage.
    Br J Surg. 2022 May 17. pii: 6586618. doi: 10.1093.
    PubMed    


  57. YAQUB S
    Comment on: Synchronous resection of primary colorectal cancer with liver metastases: Two birds with one stone?
    Br J Surg. 2022 May 17. pii: 6587119. doi: 10.1093.
    PubMed    


  58. SIRIWARDENA AK
    Author response to: Synchronous resection of primary colorectal cancer with liver metastases: Two birds with one stone?
    Br J Surg. 2022 May 17. pii: 6586615. doi: 10.1093.
    PubMed    


  59. WANG R, Quan Z, Zheng T, Wang K, et al
    Pathophysiological mechanisms of ALPPS: experimental model.
    Br J Surg. 2022;109:510-519.
    PubMed     Abstract available


  60. SALEH NB, Golse N, Abdallah M, Veziant J, et al
    Preoperative morphometric measurements of liver vasculature to predict postoperative liver failure: bicentric study.
    Br J Surg. 2022;109:554-555.
    PubMed    


  61. BJORNELV GMW, Zolic-Karlsson Z, Dueland S, Line PD, et al
    Cost-effectiveness of liver transplantation versus last-resort systemic therapy for colorectal liver metastases.
    Br J Surg. 2022;109:483-485.
    PubMed    


  62. WEI F
    Erratum to: Comment on: Laparoscopic versus open resection of intrahepatic cholangiocarcinoma: nationwide analysis.
    Br J Surg. 2022;109:551.
    PubMed    


  63. WEI T, Zhang XF, He J, Popescu I, et al
    Prognostic impact of perineural invasion in intrahepatic cholangiocarcinoma: multicentre study.
    Br J Surg. 2022 May 3. pii: 6577149. doi: 10.1093.
    PubMed     Abstract available


    April 2022
  64. RAMOUZ A, Ali-Hasan-Al-Saegh S, Shafiei S, Fakour S, et al
    Repeat liver resection for recurrent intrahepatic cholangiocarcinoma: meta-analysis.
    Br J Surg. 2022 Apr 28. pii: 6575275. doi: 10.1093.
    PubMed     Abstract available



  65. Unfamiliar liver lesions.
    Br J Surg. 2022;109:432.
    PubMed    


  66. VIGANO L, Terrone A, Costa G, Franchi E, et al
    Effect of chemotherapy on tumour-vessel relationship in colorectal liver metastases.
    Br J Surg. 2022;109:401-404.
    PubMed    


    March 2022
  67. YANG HY, Choi GH, Chin KM, Choi SH, et al
    Robotic and laparoscopic right anterior sectionectomy and central hepatectomy: multicentre propensity score-matched analysis.
    Br J Surg. 2022;109:311-314.
    PubMed    


    February 2022
  68. TANAKA S, Iida H, Ueno M, Hirokawa F, et al
    Postoperative loss of independence 1 year after liver resection: prospective multicentre study.
    Br J Surg. 2022;109:e54-e55.
    PubMed    


  69. SOREIDE K
    Time to halt perioperative chemotherapy for resectable colorectal liver metastasis?
    Br J Surg. 2022;109:242-243.
    PubMed    


  70. HOBEIKA C, Guyard C, Sartoris R, Maino C, et al
    Performance of non-invasive biomarkers compared with invasive methods for risk prediction of posthepatectomy liver failure in hepatocellular carcinoma.
    Br J Surg. 2022 Feb 10. pii: 6525857. doi: 10.1093.
    PubMed     Abstract available


  71. CRISTAUDO AT, Morris DL
    Hypothesis to explain the disparity in the proportion of liver metastases between appendiceal and colorectal cancer.
    Br J Surg. 2022 Feb 8. pii: 6524033. doi: 10.1093.
    PubMed    


  72. SIRIWARDENA AK
    Synchronous resection of primary colorectal cancer with liver metastases: two birds with one stone?
    Br J Surg. 2022 Feb 3. pii: 6521658. doi: 10.1093.
    PubMed    


    January 2022
  73. WEI F
    Erratum to: Comment on: Laparoscopic versus open resection of intrahepatic cholangiocarcinoma: nationwide analysis.
    Br J Surg. 2022 Jan 5. pii: 6498168. doi: 10.1093.
    PubMed    


    December 2021
  74. HOLMBERG M, Koppatz H, Jansson A, Hillingso JG, et al
    Secondary effects of the COVID-19 pandemic on surgical management of hepatopancreatobiliary malignancies in the Nordic capitals.
    Br J Surg. 2021 Dec 1. pii: 6447105. doi: 10.1093.
    PubMed    


  75. DUELAND S, Syversveen T, Hagness M, Grut H, et al
    Liver transplantation for advanced liver-only colorectal metastases.
    Br J Surg. 2021;108:1402-1405.
    PubMed    


    November 2021
  76. SRINIVASAN M, Shaji Mathew J, Mallick S, Nair K, et al
    Middle hepatic vein reconstruction in adult living donor liver transplantation: a randomized clinical trial.
    Br J Surg. 2021 Nov 25. pii: 6439950. doi: 10.1093.
    PubMed     Abstract available


  77. NIEDERWIESER T, Braunwarth E, Dasari BVM, Pufal K, et al
    Early postoperative arterial lactate concentrations to stratify risk of post-hepatectomy liver failure.
    Br J Surg. 2021;108:1360-1370.
    PubMed     Abstract available


  78. KABIR T, Tan ZZ, Syn NL, Wu E, et al
    Laparoscopic versus open resection of hepatocellular carcinoma in patients with cirrhosis: a meta-analysis.
    Br J Surg. 2021 Nov 10. pii: 6424997. doi: 10.1093.
    PubMed     Abstract available


  79. WELSCH T, Mussle B, Korn S, Sturm D, et al
    Pancreatoduodenectomy with or without prophylactic falciform ligament wrap around the hepatic artery for prevention of postpancreatectomy haemorrhage: a randomized clinical trial (PANDA trial).
    Br J Surg. 2021 Nov 8. pii: 6422748. doi: 10.1093.
    PubMed     Abstract available


    October 2021
  80. ZHOU Q
    Comment on: Laparoscopic and open liver resection for hepatocellular carcinoma with Child-Pugh B cirrhosis: multicentre propensity score-matched study.
    Br J Surg. 2021;108:e350.
    PubMed    


  81. ZHONG JH, Xing BC, Zhang WG, Chan AW, et al
    Repeat hepatic resection versus radiofrequency ablation for recurrent hepatocellular carcinoma: a retrospective multicentre study.
    Br J Surg. 2021 Oct 13. pii: 6395264. doi: 10.1093.
    PubMed     Abstract available


  82. SNEIDERS D, Boteon APCS, Lerut J, Iesari S, et al
    Transarterial chemoembolization of hepatocellular carcinoma before liver transplantation and risk of post-transplant vascular complications: a multicentre observational cohort and propensity score-matched analysis.
    Br J Surg. 2021 Oct 6. pii: 6382003. doi: 10.1093.
    PubMed     Abstract available


    August 2021
  83. GORGEC B, Fichtinger RS, Ratti F, Aghayan D, et al
    Comparing practice and outcome of laparoscopic liver resection between high-volume expert centres and nationwide low-to-medium volume centres.
    Br J Surg. 2021;108:983-990.
    PubMed     Abstract available


  84. KAWAGUCHI Y, Kopetz S, Tran Cao HS, Panettieri E, et al
    Contour prognostic model for predicting survival after resection of colorectal liver metastases: development and multicentre validation study using largest diameter and number of metastases with RAS mutation status.
    Br J Surg. 2021;108:968-975.
    PubMed     Abstract available


  85. MIRANDE MD, Hernandez MC, Nagorney DM
    Corrigendum to: Ingested fishbone causing a hepatic abscess.
    Br J Surg. 2021 Aug 17. pii: 6353225. doi: 10.1093.
    PubMed    


  86. RATTI F, Aldrighetti L
    Commentary On "Laparoscopic Versus Open Resection Of Intrahepatic Cholangiocarcinoma: Nationwide Analysis".
    Br J Surg. 2021 Aug 2. pii: 6335751. doi: 10.1093.
    PubMed    


    July 2021
  87. ISONIEMI H, Uutela A, Nordin A, Lantto E, et al
    Centralized repeated resectability assessment of patients with colorectal liver metastases during first-line treatment: prospective study.
    Br J Surg. 2021;108:817-825.
    PubMed     Abstract available


  88. HOBEIKA C, Cauchy F
    Reply: Commentary on 'laparoscopic versus open resection of intrahepatic cholangiocarcinoma: nationwide analysis'.
    Br J Surg. 2021 Jul 16. pii: 6322942. doi: 10.1093.
    PubMed    


    June 2021
  89. WEI F
    Comment on: Laparoscopic versus open resection of intrahepatic cholangiocarcinoma: nationwide analysis.
    Br J Surg. 2021 Jun 14. pii: 6298428. doi: 10.1093.
    PubMed    


    May 2021
  90. LAYTON GR, Chung WY, Isherwood J, Fraser RE, et al
    Endoscopic retrograde cholangiopancreatography in the COVID era: considerations for hepatobiliary and pancreatic surgery units.
    Br J Surg. 2021 May 17. pii: 6277144. doi: 10.1093.
    PubMed    


  91. HOBEIKA C, Cauchy F
    Reply: Can laparoscopic approach improve quality of care of patients with resectable intrahepatic cholangiocarcinoma? (Comment on 'laparoscopic versus open resection of intrahepatic cholangiocarcinoma: nationwide analysis').
    Br J Surg. 2021 May 17. pii: 6277143. doi: 10.1093.
    PubMed    


    April 2021
  92. LIU Y, Chang W, Zhou B, Wei Y, et al
    Conventional transarterial chemoembolization combined with systemic therapy versus systemic therapy alone as second-line treatment for unresectable colorectal liver metastases: randomized clinical trial.
    Br J Surg. 2021;108:373-379.
    PubMed     Abstract available



  93. Ingested fishbone causing a hepatic abscess.
    Br J Surg. 2021 Apr 19. pii: 6238564. doi: 10.1093.
    PubMed    



  94. Snapshot quiz.
    Br J Surg. 2021;108:270.
    PubMed    


    March 2021
  95. TAKAICHI S, Tomimaru Y, Kobayashi S, Takeda Y, et al
    Drainage after laparoscopic liver surgery in the CSGO-HBP-004 study: propensity score-matched analysis.
    Br J Surg. 2021;108:e57-e58.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.